StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a report issued on Monday morning. The firm issued a hold rating on the stock.
Milestone Scientific Stock Performance
Shares of NYSE:MLSS opened at $0.97 on Monday. The firm has a market cap of $74.91 million, a PE ratio of -9.70 and a beta of 1.08. Milestone Scientific has a 52 week low of $0.52 and a 52 week high of $1.10. The firm’s fifty day moving average is $0.97 and its 200-day moving average is $0.78.
Milestone Scientific (NYSE:MLSS – Get Free Report) last released its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). Milestone Scientific had a negative net margin of 54.87% and a negative return on equity of 60.78%. The company had revenue of $1.85 million during the quarter.
Insider Transactions at Milestone Scientific
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Articles
- Five stocks we like better than Milestone Scientific
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Should You Invest in Treasury Bills?
- What is the Australian Securities Exchange (ASX)
- Analysts Think There’s Still Time to Get in on Edgewise, Up 332%
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Stocks Raising Dividends 4X Higher Than Inflation
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.